Scholars Central

Review articlePublished 24 Feb 2006

The time has come: a new scene for PKU treatment

Authors: Luciana Lara dos Santos, Myrian de Castro Magalhães, José Nélio Januário, Marcos José Burle de Aguiar, Maria Raquel Santos Carvalho

Genetics and Molecular Research

Volume 5 · Issue 1 · Pages 33–44

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Phenylketonuria (PKU) is one of the few genetic diseases in which mental retardation can be prevented. Hence, diagnosis and treatment must be established early. PKU treatment consists of a phenylalanine-restricted diet supplemented with a phenylalanine-free mixture of amino acids. However, it is difficult to adhere to this diet. In the last decade, a better comprehension of the biochemistry, genetics and molecular basis of the disease, as well as the need for easier treatment, led to the development of several new therapeutic strategies for PKU. In the present study, we evaluated these new therapeutic options in terms of theoretical basis, methodologies, efficacy, and costs.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Genetics and Molecular Research.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalGenetics and Molecular Research
  • SubjectGenetics & Molecular Biology
  • BylineArticles whose byline prints “Luciana Lara dos Santos”
  • BylineArticles whose byline prints “Myrian de Castro Magalhães”
  • BylineArticles whose byline prints “José Nélio Januário”
  • BylineArticles whose byline prints “Marcos José Burle de Aguiar”
  • BylineArticles whose byline prints “Maria Raquel Santos Carvalho”